(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.24%) $83.77
(-1.10%) $1.620
(0.08%) $2 344.30
(0.39%) $27.46
(0.70%) $926.90
(-0.26%) $0.932
(-0.25%) $10.96
(-0.38%) $0.799
(-0.16%) $92.18
Live Chart Being Loaded With Signals
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample...
Stats | |
---|---|
Šios dienos apimtis | 671 569 |
Vidutinė apimtis | 2.16M |
Rinkos kapitalizacija | 1.14M |
EPS | $-9.91 ( 2023-11-20 ) |
Kita pelno data | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.00903 |
ATR14 | $0.149 (281.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-16 | Walsh Robert | Sell | 806 | Employee Stock option (right to buy) |
2022-11-17 | Dao-haddock Quyen Thi | Buy | 10 000 | Employee Stock Option (right to buy) |
2022-11-17 | Dao-haddock Quyen Thi | Buy | 0 | |
2022-11-17 | Dao-haddock Quyen Thi | Buy | 0 | |
2022-07-08 | Chandler Marsha Alpert | Buy | 10 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
92.29 |
Last 94 transactions |
Buy: 4 462 700 | Sell: 1 536 257 |
Tūris Koreliacija
Biocept Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
ALHC | 0.952 |
TUEM | 0.95 |
BFRI | 0.948 |
MDRX | 0.947 |
NRXP | 0.946 |
FIBK | 0.946 |
SVAC | 0.942 |
EBC | 0.941 |
CPTN | 0.94 |
SPFI | 0.937 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
AMRB | -0.973 |
QNST | -0.94 |
PTOC | -0.938 |
OBT | -0.938 |
MCFT | -0.938 |
LSTR | -0.933 |
APXI | -0.933 |
SGEN | -0.933 |
RMBS | -0.93 |
GPACU | -0.929 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Biocept Inc Koreliacija - Valiuta/Žaliavos
Biocept Inc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $25.86M |
Bruto pelnas: | $-2.58M (-9.99 %) |
EPS: | $-56.78 |
Q2 | 2023 |
Pajamos: | $589 000 |
Bruto pelnas: | $-1.96M (-332.94 %) |
EPS: | $-3.50 |
Q1 | 2023 |
Pajamos: | $673 000 |
Bruto pelnas: | $-2.36M (-349.93 %) |
EPS: | $-12.32 |
Q4 | 2022 |
Pajamos: | $-10.29M |
Bruto pelnas: | $-14.59M (141.88 %) |
EPS: | $-32.57 |
Financial Reports:
No articles found.
Biocept Inc
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.